Abstract
Background
Intermittent hypoxia (IH) is a factor involved in the incidence and progression of lung adenocarcinoma (LUAD). Bone marrow-derived bone mesenchymal stem cells (BMSCs)-derived exosomes are related to the promotion of tumor development. The objective of this experiment was to clarify the mechanism of exosomes from BMSCs in promoting the progression of LUAD induced by IH.
Methods
This study examined if IH BMSCS-derived exosomes affect the malignancy of LUAD cells in vitro. Dual-luciferase assays were conducted to confirm the target of miR-31-5p with WD repeat domain 5 (WDR5). We further investigated whether or not exosomal miR-31-5p or WDR5 could regulate epithelial–mesenchymal transition (EMT). We determined the effect of IH exosomes using a tumorigenesis model in vivo.
Results
miR-31-5p entered into LUAD cells via exosomes. MiR-31-5p was greatly upregulated in IH BMSCs-derived exosomes compared with RA exosomes. Increased expression of exosomal miR-31-5p induced by IH was discovered to target WDR5 directly, increased activation of WDR5, and significantly facilitated EMT, thereby promoting LUAD progression.
Conclusions
The promoting effect of IH on LUAD is achieved partly through BMSCs-derived exosomal miR-31-5p triggering WDR5 and promoting EMT.
Similar content being viewed by others
Data availability
The data for this study are available from the corresponding author.
References
Eckert DJ, Malhotra A (2008) Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5(2):144–153. https://doi.org/10.1513/pats.200707-114MG
Martinez-Garcia MA, Campos-Rodriguez F, Duran-Cantolla J, de la Pena M, Masdeu MJ, Gonzalez M, Del Campo F, Serra PC, Valero-Sanchez I, Ferrer MJ, Marin JM, Barbe F, Martinez M, Farre R, Montserrat JM (2014) Obstructive sleep apnea is associated with cancer mortality in younger patients. Sleep Med 15(7):742–748. https://doi.org/10.1016/j.sleep.2014.01.020
Almendros I, Montserrat JM, Ramirez J, Torres M, Duran-Cantolla J, Navajas D, Farre R (2012) Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur Respir J 39(1):215–217. https://doi.org/10.1183/09031936.00185110
Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, Duran-Cantolla J, Pena Mde L, Masdeu MJ, Gonzalez M, Campo F, Gallego I, Marin JM, Barbe F, Montserrat JM, Farre R (2013) Association between obstructive sleep apnea and cancer incidence in a large multicenter Spanish cohort. Am J Respir Crit Care Med 187(1):99–105. https://doi.org/10.1164/rccm.201209-1671OC
Almendros I, Montserrat JM, Torres M, Dalmases M, Cabanas ML, Campos-Rodriguez F, Navajas D, Farre R (2013) Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Respir Physiol Neurobiol 186(3):303–307. https://doi.org/10.1016/j.resp.2013.03.001
Chen A, Sceneay J, Godde N, Kinwel T, Ham S, Thompson EW, Humbert PO, Moller A (2018) Intermittent hypoxia induces a metastatic phenotype in breast cancer. Oncogene 37(31):4214–4225. https://doi.org/10.1038/s41388-018-0259-3
Liu L, Liu W, Wang L, Zhu T, Zhong J, Xie N (2017) Hypoxia-inducible factor 1 mediates intermittent hypoxia-induced migration of human breast cancer MDA-MB-231 cells. Oncol Lett 14(6):7715–7722. https://doi.org/10.3892/ol.2017.7223
Gutsche K, Randi EB, Blank V, Fink D, Wenger RH, Leo C, Scholz CC (2016) Intermittent hypoxia confers pro-metastatic gene expression selectively through NF-kappaB in inflammatory breast cancer cells. Free Radic Biol Med 101:129–142. https://doi.org/10.1016/j.freeradbiomed.2016.10.002
Liu Y, Song X, Wang X, Wei L, Liu X, Yuan S, Lv L (2010) Effect of chronic intermittent hypoxia on biological behavior and hypoxia-associated gene expression in lung cancer cells. J Cell Biochem 111:554–563
Gu X, Zhang J, Shi Y, Shen H, Li Y, Chen Y, Liang L (2021) ESM1/HIF-1α pathway modulates chronic intermittent hypoxia-induced non-small-cell lung cancer proliferation, stemness and epithelial-mesenchymal transition. Oncol Rep 45(3):1226–1234
Torre LA, Siegel RL, Jemal A (2016) Lung cancer statistics. Adv Exp Med Biol 893:1–19
Denisenko TV, Budkevich IN, Zhivotovsky B (2018) Cell death-based treatment of lung adenocarcinoma. Cell Death Dis 9(2):117
Falcone G, Felsani A, D’Agnano I (2015) Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res 34:32. https://doi.org/10.1186/s13046-015-0148-3
Ohno S, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T, Gotoh N, Kuroda M (2013) Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21(1):185–191. https://doi.org/10.1038/mt.2012.180
Shibayama Y, Kondo T, Ohya H, Fujisawa S, Teshima T, Iseki K (2015) Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients. Oncol Rep 33(5):2176–2182. https://doi.org/10.3892/or.2015.3839
Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang JA-O (2019) Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer 18(1):40
Wang G, Ji X, Li P, Wang W (2022) Human bone marrow mesenchymal stem cell-derived exosomes containing microRNA-425 promote migration, invasion and lung metastasis by down-regulating CPEB1. Regen Ther 20:107–116
Liu X, Jiang F, Wang Z, Tang L, Zou B, Xu P, Yu TA-O (2021) Hypoxic bone marrow mesenchymal cell-extracellular vesicles containing miR-328-3p promote lung cancer progression via the NF2-mediated Hippo axis. J Cell Mol Med 25(1):96–109
Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D, Reichardt W, Bronsert P, Brunton VG, Pilarsky C, Winkler TH, Brabletz S, Stemmler MP, Brabletz T (2017) The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol 19(5):518–529
Scheel C, Weinberg RA (2012) Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22(5–6):396–403
Terry SA-O, Savagner P, Ortiz-Cuaran S, Mahjoubi L, Saintigny P, Thiery JP, Chouaib S (2017) New insights into the role of EMT in tumor immune escape. Mol Oncol 11(7):824–846
De Craene B, Berx G (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 13(2):97–110
Carugo A, Genovese G, Seth S, Nezi L, Rose JL, Bossi D, Cicalese A, Shah PK, Viale A, Pettazzoni PF, Akdemir KC, Bristow CA, Robinson FS, Tepper J, Sanchez N, Gupta S, Estecio MR, Giuliani V, Dellino GI, Riva L, Yao W, Di Francesco ME, Green T, D’Alesio C, Corti D, Kang Y, Jones P, Wang H, Fleming JB, Maitra A, Pelicci PG, Chin L, DePinho RA, Lanfrancone L, Heffernan TP, Draetta GF (2016) In vivo functional platform targeting patient-derived xenografts identifies WDR5-Myc association as a critical determinant of pancreatic cancer. Cell Rep 16(1):133–147
Chen T, Li K, Liu Z, Liu J, Wang Y, Sun R, Li Z, Qiu B, Zhang X, Ren G, Xu Y, Zhang Z (2021) WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways. Mol Ther 29(6):2134–2150
Tan X, Chen S, Wu J, Lin J, Pan C, Ying X, Pan Z, Qiu L, Liu R, Geng R, Huang W (2017) PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407. Cell Death Dis 8(3):e2686
Ren J, Liu W, Li GC, Jin M, You ZX, Liu HG, Hu Y (2018) Atorvastatin attenuates myocardial hypertrophy induced by chronic intermittent hypoxia in vitro partly through miR-31/PKCε pathway. Curr Med Sci 38(3):405–412
Wu DM, Wen X, Han XR, Wang S, Wang YJ, Shen M, Fan SH, Zhang ZF, Shan Q, Li MQ, Hu B, Lu J, Chen GQ, Zheng YL (2019) Bone marrow mesenchymal stem cell-derived exosomal microRNA-126-3p inhibits pancreatic cancer development by targeting ADAM9. Mol Ther Nucleic Acids 16:229–245. https://doi.org/10.1016/j.omtn.2019.02.022
Wu H, Zhou J, Mei S, Wu D, Mu Z, Chen B, Xie Y, Ye Y, Liu J (2017) Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med 21(6):1228–1236. https://doi.org/10.1111/jcmm.13056
Qu Z, Wu J, Wu J, Luo D, Jiang C, Ding Y (2016) Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. J Exp Clin Cancer Res 35(1):159. https://doi.org/10.1186/s13046-016-0430-z
Lasser C, Eldh M, Lotvall J (2012) Isolation and characterization of RNA-containing exosomes. J Vis Exp 59:e3037. https://doi.org/10.3791/3037
Yu F, Liang M, Huang Y, Wu W, Zheng B, Chen C (2021) Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling. J Exp Clin Cancer Res 40(1):179
Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, Just A, Remke J, Zimmer K, Zeug A, Ponimaskin E, Schmiedl A, Yin X, Mayr M, Halder R, Fischer A, Engelhardt S, Wei Y, Schober A, Fiedler J, Thum T (2014) Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124(5):2136–2146. https://doi.org/10.1172/jci70577
Ren J, Liu W, Deng Y, Li GC, Pan YY, Xie S, Jin M, Liu HG (2017) Losartan attenuates aortic endothelial apoptosis induced by chronic intermittent hypoxia partly via the phospholipase C pathway. Sleep Breath 21(3):679–689. https://doi.org/10.1007/s11325-017-1479-4
Qi J, Zhou Y, Jiao Z, Wang X, Zhao Y, Li Y, Chen H, Yang L, Zhu H, Li Y (2017) Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through hedgehog signaling pathway. Cell Physiol Biochem 42(6):2242–2254. https://doi.org/10.1159/000479998
Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W (2012) Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett 315(1):28–37. https://doi.org/10.1016/j.canlet.2011.10.002
Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(26):1032–1046
Song FA-O, Xuan Z, Yang X, Ye X, Pan Z, Fang Q (2020) Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. J Cell Biochem 121(3):2690–2703
Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, Olokpa E, Zariff A, Gunaratne PH, Matzuk MM, Anderson ML (2010) Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res 70(5):1906–1915
Edmonds MD, Boyd KL, Moyo T, Mitra R, Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T, Eischen CM (2016) MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Invest 126(1):349–364
Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470–1476. https://doi.org/10.1038/ncb1800
Li L, Li C, Wang S, Wang Z, Jiang J, Wang W, Li X, Chen J, Liu K, Li C, Zhu G (2016) Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res 76(7):1770–1780. https://doi.org/10.1158/0008-5472.Can-15-1625
Ji A, Qian L, Tian Z, Cui JA-O (2021) WDR5 promotes the proliferation of lung adenocarcinoma by inducing SOX9 expression. Biomark Med 15(17):1599–1609
Chen JC, Hwang JH (2014) Sleep apnea increased incidence of primary central nervous system cancers: a nationwide cohort study. Sleep Med 15(7):749–754. https://doi.org/10.1016/j.sleep.2013.11.782
Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farre R (2012) Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 186(2):190–194. https://doi.org/10.1164/rccm.201201-0130OC
Peppard PE, Nieto FJ (2013) Here come the sleep apnea-cancer studies. Sleep 36(10):1409–1411. https://doi.org/10.5665/sleep.3018
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA (2008) Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 83(5):584–594. https://doi.org/10.4065/83.5.584
Dong HX, Wang R, Jin XY, Zeng J, Pan J (2018) LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p. J Cell Physiol 233(5):4126–4136
Guo X, Liu Y, Kim JL, Kim EY, Kim EQ, Jansen A, Li K, Chan M, Keenan BT, Conejo-Garcia J, Lim DC (2019) Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse. PLoS ONE 14(2):e0212930. https://doi.org/10.1371/journal.pone.0212930
Rashed MH, Bayraktar E, Helal GK, Abd-Ellah MF, Amero P, Chavez-Reyes A, Rodriguez-Aguayo C (2017) Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci 18(3):538. https://doi.org/10.3390/ijms18030538
Deng G, Qu J, Zhang Y, Che X, Cheng Y, Fan Y, Zhang S, Na D, Liu Y, Qu X (2017) Gastric cancer-derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier. FEBS Lett 591(14):2167–2179. https://doi.org/10.1002/1873-3468.12722
Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, Camussi G (2011) Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 71(15):5346–5356. https://doi.org/10.1158/0008-5472.Can-11-0241
Xu Y, Shen L, Li F, Yang J, Wan X, Ouyang M (2019) microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. J Cell Physiol 234(11):21380–21394. https://doi.org/10.1002/jcp.28747
Liu X, Sun L, Zhang S, Zhang S, Li WA-O (2020) GINS2 facilitates epithelial-to-mesenchymal transition in non-small-cell lung cancer through modulating PI3K/Akt and MEK/ERK signaling. J Cell Physiol 235(11):7747–7756
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659
Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. LID. https://doi.org/10.3402/jev.v3.23743[doi].JExtracellVesicles3
Mlcochova J, Faltejskova-Vychytilova P, Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss I, Vyzula R, Negrini M, Slaby O (2015) MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab. Oncotarget 6(36):38695–38704
Nosho K, Igarashi H, Nojima M, Ito M, Maruyama R, Yoshii S, Naito T, Sukawa Y, Mikami M, Sumioka W, Yamamoto E, Kurokawa S, Adachi Y, Takahashi H, Okuda H, Kusumi T, Hosokawa M, Fujita M, Hasegawa T, Okita K, Hirata K, Suzuki H, Yamamoto H, Shinomura Y (2014) Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway. Carcinogenesis 35(4):776–783
Wang CJ, Stratmann J, Zhou Z-G, Sun X-F (2010) Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 10:616
Zhang S, Hong Z, Chai Y, Liu Z, Du Y, Li Q, Liu Q (2017) CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation. Biochem Biophys Res Commun 488(1):101–108
Thomas LR, Foshage AM, Weissmiller AM, Tansey WP (2015) The MYC-WDR5 nexus and cancer. Cancer Res 75(19):4012–4015
Xu WA-O, Li J, Li L, Hou T, Cai X, Liu T, Yang X, Wei H, Jiang C, Xiao J (2019) FOXD3 suppresses tumor-initiating features in lung cancer via transcriptional repression of WDR5. Stem Cells 37(5):582–592
Funding
This study was funded by the National Natural Science Foundation of China (grant 82100106).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
All applicable guidelines for the care and use of animals were followed.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ren, J. Intermittent hypoxia BMSCs-derived exosomal miR-31-5p promotes lung adenocarcinoma development via WDR5-induced epithelial mesenchymal transition . Sleep Breath 27, 1399–1409 (2023). https://doi.org/10.1007/s11325-022-02737-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11325-022-02737-5